Clopidogrel use in chronic coronary syndrome: a fragile lifelong choice

Xavier Rossello¹, Anna Meta Dyrvig Kristensen²

Affiliations

¹ Cardiology Department, Hospital Universitari Son Espases, Institut d'Investigació Sanitària Illes Balears, Palma de Mallorca 07120, Spain; Facultad de Medicina, Universitat Illes Balears, Palma de Mallorca, Spain; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain. Electronic address: x.rossello@ucl.ac.uk.
² Department of Cardiology, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark.

PMID: 40174593
DOI: 10.1016/S0140-6736(25)00562-8

Comment

Clopidogrel use in chronic coronary syndrome: a fragile lifelong choice

Xavier Rossello et al. Lancet. 2025.

. 2025 Apr 12;405(10486):1208-1209.

doi: 10.1016/S0140-6736(25)00562-8. Epub 2025 Mar 30.

Authors

Xavier Rossello¹, Anna Meta Dyrvig Kristensen²

Affiliations

¹ Cardiology Department, Hospital Universitari Son Espases, Institut d'Investigació Sanitària Illes Balears, Palma de Mallorca 07120, Spain; Facultad de Medicina, Universitat Illes Balears, Palma de Mallorca, Spain; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain. Electronic address: x.rossello@ucl.ac.uk.
² Department of Cardiology, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark.

PMID: 40174593
DOI: 10.1016/S0140-6736(25)00562-8

No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests. XR was Task Force Co-ordinator of the 2023 European Society of Cardiology guidelines for the management of acute coronary syndromes and the 2024 guidelines for the management of chronic coronary syndromes.

Comment on

Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial.
Choi KH, Park YH, Lee JY, Jeong JO, Kim CJ, Yun KH, Lee HC, Chang K, Park MW, Bae JW, Doh JH, Cho BR, Kim HY, Kim W, Kim U, Rha SW, Hong YJ, Lee HJ, Ahn SG, Kim DI, Cho JH, Her SH, Jeon DS, Han SH, Lee JB, Lee CW, Kang D, Lee JM, Park TK, Yang JH, Lee SY, Choi SH, Gwon HC, Song YB, Hahn JY; SMART-CHOICE 3 investigators. Choi KH, et al. Lancet. 2025 Apr 12;405(10486):1252-1263. doi: 10.1016/S0140-6736(25)00449-0. Epub 2025 Mar 30. Lancet. 2025. PMID: 40174599 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Clopidogrel use in chronic coronary syndrome: a fragile lifelong choice

Affiliations

Clopidogrel use in chronic coronary syndrome: a fragile lifelong choice

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

LinkOut - more resources

Full Text Sources